Product
Treatment Group
2 clinical trials
4 indications
Indication
Neonatal sepsisIndication
Cervical CancerIndication
Immune Checkpoint InhibitorIndication
ChemoradiotherapyClinical trial
The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis (Review of Malondialdehyde, Interleukin-6, Interleukin-8, Absolute Neutrophil Counts, and Sepsis Score)Status: Completed, Estimated PCD: 2023-10-05
Clinical trial
Tislelizumab (Anti-PD-1) Combined With Definitive Chemoradiotherapy in Recurrent Cervical Cancer (PILOT-2020-511): a Single-arm, Phase 2 TrialStatus: Recruiting, Estimated PCD: 2023-12-31